Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Pediatric Dermatology Morbidity & Mortality

Description

In a morbidity and mortality panel on pediatric dermatology, the speaker presented three cases highlighting common but serious issues encountered in practice. The first case involved a 15-year-old girl diagnosed with DRESS, a drug reaction that led to acute liver failure exacerbated by over-the-counter Tylenol, emphasizing the need for vigilance in monitoring medication use and educating families about potential risks. The second case detailed a three-month-old boy who developed life-threatening hypoglycemia after starting propranolol for an infantile hemangioma, illustrating the importance of thorough education on medication administration, particularly during illness. The final case concerned a 15-year-old boy with hidradenitis suppurativa, where treatment challenges were exacerbated by logistical issues and the complexities of managing immune-modulating therapies in a Down syndrome patient, leading to concerns about lymphoma risks associated with biologics. The speaker reflected on the significant learning opportunities these cases provided, focusing on the importance of clear communication, interprofessional collaboration, and awareness of unique patient populations.

View more

Conclusions

  • The first case highlights the critical importance of monitoring acetaminophen (Tylenol) use in patients with drug-induced liver injuries to prevent further damage.
  • Education about medication risks and proper dosing should be made a priority for both patients and healthcare providers.
  • Propranolol can lead to hypoglycemia, especially in patients with concurrent illnesses affecting intake and absorption.
  • Close monitoring of patients on propranolol and thorough education on feeding and medication timing are essential to prevent adverse events.
  • Early recognition and accurate diagnosis of hidradenitis suppurativa in pediatric patients is vital for effective treatment.
  • Sequential treatment failures in hidradenitis suppurativa underscore the need for tailored therapy and persistent advocacy for insurance approvals.
  • Understanding the limitations of telemedicine can prevent oversight in patient evaluations and ensure comprehensive care.